Trisomy 8 in Stage I and Stage III Ovarian Cancer Detected by Fluorescencein SituHybridization
Authors:
- Hon Fong L MarkHMHon Fong L Mark
- Alaa M AfifyAAAlaa M Afify
- Bruce A WernessBWBruce A Werness
- Sam DasSDSam Das
- Seamus MarkSMSeamus Mark
- Mangala SamyMSMangala Samy
- 1 April 1999
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 66 (1) , 76-81
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Abnormal Chromosome 8 Copy Number in Stage I to Stage IV Breast Cancer Studied by Fluorescence In Situ HybridizationCancer Genetics and Cytogenetics, 1999
- Trisomy 8 in Embryonal Rhabdomyosarcoma Detected by Fluorescence In Situ HybridizationCancer Genetics and Cytogenetics, 1999
- Interphase cytogenetics for studying solid tumorsCancer, 1998
- Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage i and stage ii infiltrating ductal carcinoma of the breastCancer Genetics and Cytogenetics, 1997
- Stage I and Stage II Infiltrating Ductal Carcinoma of the Breast Analyzed for Chromosome 8 Copy Number Using Fluorescent in situ HybridizationPathobiology, 1997
- Fluorescentin situ hybridization assessment of chromosome 8 copy number in breast cancerBreast Cancer Research and Treatment, 1996
- Chromosome abnormalities in human epithelial ovarian malignanciesGynecologic Oncology, 1990
- Abnormal chromosomes including small metacentrics in 14 ovarian cancersCancer Genetics and Cytogenetics, 1987
- AnnouncementGynecologic Oncology, 1986
- Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.Proceedings of the National Academy of Sciences, 1986